MATK/CTK

MATK, also known as CTK or CHK (CSK-homologous kinase), is the second member of the Csk family. It phosphorylates the C-terminal regulatory tyrosine of Src-family kinases and additionally inhibits them through direct SH2-mediated binding, providing a dual repression mechanism that is unusually potent against Src, LYN and LCK. Unlike ubiquitous CSK, MATK expression is largely restricted to normal and malignant cells of hematopoietic origin and to the brain, where it modulates differentiation of myeloid and megakaryocytic lineages and neuronal maturation. MATK can exert context-dependent tumor-suppressive effects, being downregulated in some lymphoid malignancies. Its tight, non-catalytic Src inhibition makes MATK a biochemically distinctive member among regulatory tyrosine kinases.